Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers

Journal of the Royal Society of Medicine

Volumn 104, Issue 9, 2011, Pages 383-386

  Chalmers, Iain ^a  

^a Summertown Pavilion   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOMYCIN;

HUMAN; LUNG TUBERCULOSIS; NOTE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EID: 80052641926     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.2011.11k023     Document Type: Note

References (39)

1. Rosser Matthews J. Quantification and the Quest for Medical Certainty. Princeton, NJ: Princeton University Press, 1995
2. Marks HM. The Progress of Experiment. Cambridge: Cambridge University Press, 2000
3. Gaudillière J-P. Beyond one-case statistics: mathematics, medicine, and the management of health and disease in the postwar era. In: Bottazzini U, Dalmedico AD, eds. Changing images in mathematics: from the French Revoluton to the New Millennium. London: Routledge, 2001:283
4. Magnello E. The introduction of mathematical statistics into medical research: the roles of Karl Pearson, Major Greenwood and Austin Bradford Hill. In: Magnello E, Hardy A, eds. The road to medical statistics. Amsterdam: Rodopi, 2002
5. Chalmers I. Assembling comparison groups to assess the effects of health care. J R Soc Med 1997;90:379-86
6. Chalmers I. Why transition from alternation to randomisation in clinical trials was made. BMJ 1999;319:1372
7. Chalmers I. Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments. Int J Epidemiol 2001;30:1156-64
8. Edwards MV. Control and the therapeutic trial, 1918-1948. MD thesis. London: University of London, 2004
9. Chalmers I. Statistical theory was not the reason that randomisation was used in the British Medical Research Council's clinical trial of streptomycin for pulmonary tuberculosis. In: Jorland G, Opinel A, Weisz G, eds. Body counts: medical quantification in historical and sociological perspectives. Montreal: McGill-Queens University Press, 2005:309-34
10. Edwards MV. Control and the therapeutic trial. Amsterdam: Rodopi, 2006
11. Chalmers I. Explaining the unbiased creation of treatment comparison groups. Lancet 2009;374:1670-1
12. Petrarca F. Rerum Senilium Libri. Liber XIV, Epistola 1. Letter to Boccaccio (V.3). 1364
13. Massey I. A short and plain account of inoculation. With some remarks on the main argument made use of to recommend that practice, by Mr. Maitland and others. To which is added, a letter to the learned James Jurin, M.D.R.S. Secr. Col. Reg. Med. Lond. Soc. In answer to his letter to the learned Dr. Cotesworth, and his comparison between the mortality of natural and inoculated small pox. The second edition. London: W Meadows, 1723
14. Lind J. A treatise of the scurvy. In three parts. Containing an inquiry into the nature, causes and cure, of that disease. Together with a critical and chronological view of what has been published on the subject. Edinburgh: A Kincaid and A Donaldson, 1753
15. Silverman WA, Chalmers I. Casting and drawing lots: a time-honoured way of dealing with uncertainty and for ensuring fairness. The James Lind Library 2002. See www. jameslindlibrary.org
16. Hamilton AL. Dissertatio medica inauguralis de synocho castrensi (Inaugural medical dissertation on camp fever). Edinburgh: J Ballantyne, 1816
17. Milne I, Chalmers I. Hamilton's report of a controlled trial of bloodletting, 1816. The James Lind Library 2002. See www. jameslindlibrary.org
18. Balfour TG. Quoted in West C. Lectures on the diseases of infancy and childhood. London: Longman, Brown, Green and Longmans, 1854
19. Chalmers I, Toth B. 19th century controlled trials to test whether belladonna prevents scarlet fever. The James Lind Library 2009. See www.jameslindlibrary.org
20. Bullowa JGM. The use of antipneumococcic refined serum in lobar pneumonia: data necessary for a comparison between cases treated with serum and cases not so treated, and the importance of a significant control series of cases. JAMA 1928;90:1354-8
21. Choksy KBNH. On recent progress in serum-therapy of plague. BMJ 1908;1:1282-4
22. Cecil RL, Plummer N. Pneumococcus Type I pneumonia - a study of eleven hundred and sixty-one cases, with especial reference to specific therapy. JAMA 1930;95:1547-53
23. Cousin M. Des éruptions consecutives aux injections de sérum antidiphthérique et de leur traitement prophylactique par l'ingestion de clorure de calcium. Thèse pour le Doctorat en médicine. Paris: Jules Rousset, 1905
24. Netter A. Efficacité de l'ingestion de chlorure de calcium comme moyen préventif des éruptions consecutives aux injections de sérum. Séances et Mémoires de la Société de Biologie 1906;58:279-80
25. Wagner-Jauregg J. Ueber die Infektionsbehandlung der progressiven Paralyse [On infection treatment of progressive paralysis]. Münchener Medizinische Wochenschrift 1931;78:4-7
26. Fisher RA. The design of experiments. Edinburgh: Oliver and Boyd, 1935
27. Armitage P. Randomisation and alternation: a note on Diehl et al. The James Lind Library 2002. Seewww.jameslindlibrary. org
28. Hill AB. Principles of medical statistics. London: Lancet, 1937
29. Medical Research Council Therapeutic Trials Committee. The serum treatment of lobar pneumonia. BMJ 1934;1:241-5
30. Medical Research Council. Clinical trial of patulin in the common cold. Lancet 1944;2:373-5
31. Clarke M. The 1944 patulin trial of the British Medical Research Council: an example of how concerted common purpose can get reliable answers to important questions very quickly. The James Lind Library 2004. See www. jameslindlibrary.org
32. Chalmers I, Clarke M. The 1944 Patulin Trial: the first properly controlled multicentre trial conducted under the aegis of the British Medical Research Council. Int J Epidemiol 2004;32:253-60
33. Medical Research Council. Streptomycin treatment of pulmonary tuberculosis: a Medical Research Council investigation. BMJ 1948;2:769-82
34. Doll R. The controlled trial. Postgrad Med J 1984;60:719-24
35. Doll R. Darwin Lecture. Development of therapeutic trials in preventive and therapeutic medicine. J Biosoc Sci 1991;23:365-78
36. Podolsky SH. Pneumonia before antibiotics: therapeutic evolution and evaluation in Twentieth-Century America. Baltimore, MD: Johns Hopkins University Press, 2006
37. Podolsky SH. Jesse Bullowa, specific treatment for pneumonia, and the development of the controlled clinical trial. The James Lind Library 2008. Seewww.jameslindlibrary. org
38. Doll R. The role of data monitoring committees. In: Duley L, Farrell B, eds. Clinical Trials. London: BMJ Books, 2002:97-104
39. Cox DR. Randomization for concealment. The James Lind Library 2009. See www.jameslindlibrary.org